Literature DB >> 10779749

Delayed and separate costimulation in vitro supports the evidence of a transient "excited" state of CD8+ T cells during activation.

N Pardigon1, C Cambouris, N Bercovici, F Lemaître, R Liblau, P Kourilsky.   

Abstract

Although the two-signal model for T cell activation states that a signal-1 through the TCR and a costimulatory signal-2 are required for optimal stimulation, it is now clear that the requirement for costimulation can be bypassed under certain conditions. We previously reported that this is the case for naive CD8+ T cells in vitro. In the present study we tested the effect of signal-2 when delivered after signal-1 has been disrupted. Naive CD8+ T cells from TCR transgenic mice were stimulated in vitro by using immobilized recombinant single-chain MHC molecules alone as signal-1. This signal was then stopped after different lengths of time, and anti-CD28 mAb as signal-2 was given either immediately or after a time lag. We found that signal-2 can potentiate a short signal-1 when added sequentially. Moreover, a time lag between the two signals does not abolish this potentiation. If the strength of signal-1, but not its duration, is increased, then the time lag between the delivery of signals 1 and 2 can be lengthen without loss of potentiation. Together, our results indicate that the two signals do not need to be delivered concomitantly to get optimal T cell activation. We suggest that the CD8+ T cells can reach a transient "excited" state after being stimulated with signal-1 alone, characterized by the cell's ability to respond to separate and delayed signal-2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779749     DOI: 10.4049/jimmunol.164.9.4493

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Effect of Hejie decoction on T cell immune state of chronic hepatitis B patients.

Authors:  Shi-Jun Zhang; Ze-Xiong Chen; Shao-Xian Lao; Bi-Jun Huang
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

2.  CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.

Authors:  Soraya Maria Menezes; Daniele Decanine; David Brassat; Ricardo Khouri; Saul V Schnitman; Ramon Kruschewsky; Giovanni López; Carolina Alvarez; Michael Talledo; Eduardo Gotuzzo; Anne-Mieke Vandamme; Bernardo Galvão-Castro; Roland Liblau; Johan Van Weyenbergh
Journal:  J Neuroinflammation       Date:  2014-01-29       Impact factor: 8.322

3.  Expression of CD80 and CD86 on B cells during coxsackievirus B3-induced acute myocarditis.

Authors:  Yanlan Huang; Bin Wei; Xingcui Gao; Yan Deng; Weifeng Wu
Journal:  Cent Eur J Immunol       Date:  2020-01-20       Impact factor: 2.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.